Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: Discovery of MK-5286

The strategy and SAR studies that led to the discovery of a novel potent and orally available 5-lipoxygenase (5-LO) inhibitor 3-(4-fluorophenyl)-6-({4-[(1S)-1-hydroxy-1-(trifluoromethyl) propyl]-1H-1,2,3-triazol-1-yl} methyl)-1-benzothiophene-2-carboxamide ((S)-21 or MK-5286) were described. (C) 2010 Elsevier Ltd. All rights reserved.